Atlas Trials

Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer

Clinical trial NCT00597597 · TERMINATED

Trial details

NCT number
NCT00597597
Sponsor
Rush University Medical Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2007-04-01
Primary completion
2011-04-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.